Copyright
©The Author(s) 2024.
World J Psychiatry. Mar 19, 2024; 14(3): 380-387
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.380
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.380
Table 1 General information of patients
| Feature | AD group (n = 60) | Control group (n = 60) | P value |
| Age (yr) | 73.5 ± 6.2 | 72.8 ± 5.9 | 0.452 |
| Gender (male/female) | 28/32 | 30/30 | 0.743 |
| Years of education | 11.4 ± 2.3 | 11.8 ± 2.1 | 0.321 |
- Citation: Liu ZL, Hua FF, Qu L, Yan N, Zhang HF. Evaluating serum CXCL12, sCD22, Lp-PLA2 levels and ratios as biomarkers for diagnosis of Alzheimer's disease. World J Psychiatry 2024; 14(3): 380-387
- URL: https://www.wjgnet.com/2220-3206/full/v14/i3/380.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i3.380